Held on January 27, 2021
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has had a devastating impact on the course of the global tuberculosis (TB) crisis. Already, in 2020, an excess of 400,000 people died from TB as a result of the impact of COVID-19 on TB diagnosis, prevention and treatment. Unless radical action is taken, between now and 2025 an additional 6.5 million people will become sick with TB. These dire predictions, however, are not inevitable, as TB preventive therapy (TPT) can effectively stop those who have been infected with TB from becoming sick with TB disease. This symposium focused on effective models for implementing TPT and included: (1) an update from the World Health Organization on global progress rolling out TPT; (2) presentation of program-level examples of TPT roll out from Pakistan, South Africa, Peru, and the CaP TB project; (3) perspectives from the academic community, civil society, donors, and affected peoples; and (4) closing remarks on urgent actions for improving TB diagnosis, prevention and treatment during the COVID-19 crisis from Dr. Madhukar Pai of McGill University.
See below for a list of speakers and the links to their bios and their presentations, as well as full-length recordings of this symposium in both English and Spanish.
Simposio: Terapia Preventiva de la Tuberculosis
Realizado el 27 de enero de 2021
Vea a continuación una lista de ponentes, los enlaces a sus biografías y sus presentaciones, así como grabaciones completas de este simposio en inglés y español.
|Ademola Osigbesan||Ana Karina Millones||Erika Mohr-Holland|
|Jennifer Furin||Lynette Mabote||Martina Casenghi|
|Matteo Zignol||Sevim Ahmedov||Sue Swindells|